ACB Share Price Performance

ACB Community Fair Values

Aurora Cannabis
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
EU GMP And TGA Expertise Will Expand Global Cannabis Reach
Key Takeaways Strategic international expansion and regulatory changes in key markets could significantly boost future revenues and medical cannabis margins. Strong financial position enables strategic investments, potentially enhancing future earnings and long-term shareholder value.
View narrative
CA$10.75
FV
27.3% undervalued intrinsic discount
12.38%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
3 days ago author updated this narrative
Your Fair Value
CA$
Current Price
CA$7.8119.2% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent ACB News & Updates

After Leaping 29% Aurora Cannabis Inc. (TSE:ACB) Shares Are Not Flying Under The Radar

May 23

EU GMP And TGA Expertise Will Expand Global Cannabis Reach

Apr 26 Strategic international expansion and regulatory changes in key markets could significantly boost future revenues and medical cannabis margins.

Aurora Cannabis Inc. Competitors

View more competitors

Canadian Market Performance

0.9%

9.1%

15.7%

6.2%

The Materials sector gained 4.6% while the market remained flat over the last week. As for the longer term, the market has risen 16% in the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum. Market details ›

Aurora Cannabis Stock Price

ACB Share Price Performance

ACB Community Fair Values

EU GMP And TGA Expertise Will Expand Global Cannabis Reach

Recent ACB News & Updates

Aurora Cannabis Inc. Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22

Aurora Cannabis Inc. to Report Q4, 2025 Results on Jun 18, 2025

Aurora Cannabis Inc., Annual General Meeting, Aug 08, 2025

After Leaping 29% Aurora Cannabis Inc. (TSE:ACB) Shares Are Not Flying Under The Radar

EU GMP And TGA Expertise Will Expand Global Cannabis Reach

Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom

Aurora Cannabis Inc. Announces the Discovery of a Novel Source of Genetic Resistance Against Powdery Mildew, PM2

New major risk - Revenue and earnings growth

Aurora Cannabis Inc. Competitors

🎢 Opportunities In The Turbulent Transition To Greener Energy

🤖 A.I. Enters the “Show Me The Money” Phase